FDA approves oral vasopressin antagonist.
Thompson
Cheryl A
CA
D065092:Antidiuretic Hormone Receptor Antagonists; D001552:Benzazepines / Q000009:adverse effects / Q000627:therapeutic use*; D000075202:Contraindications; D017277:Drug Approval; D004348:Drug Labeling; D006801:Humans; D007010:Hyponatremia / Q000188:drug therapy*; D000077602:Tolvaptan; D014481:United States; D014486:United States Food and Drug Administration
D065092:Antidiuretic Hormone Receptor Antagonists; D001552:Benzazepines; D000077602:Tolvaptan